<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://pharmacopedia.wiki/index.php?action=history&amp;feed=atom&amp;title=Propranolol</id>
	<title>Propranolol - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://pharmacopedia.wiki/index.php?action=history&amp;feed=atom&amp;title=Propranolol"/>
	<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Propranolol&amp;action=history"/>
	<updated>2026-05-28T19:19:20Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.46.0-beta</generator>
	<entry>
		<id>https://pharmacopedia.wiki/index.php?title=Propranolol&amp;diff=4613&amp;oldid=prev</id>
		<title>MDElliottMD: Em-dash sweep: replace em-dash with comma per project rule; PendellsCorner verbatim quotes preserved.</title>
		<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Propranolol&amp;diff=4613&amp;oldid=prev"/>
		<updated>2026-05-19T03:16:10Z</updated>

		<summary type="html">&lt;p&gt;Em-dash sweep: replace em-dash with comma per project rule; PendellsCorner verbatim quotes preserved.&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw-interface=&quot;&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 03:16, 19 May 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l15&quot;&gt;Line 15:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 15:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| legal             = Rx-only in US&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| legal             = Rx-only in US&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| mechanism         = Non-selective competitive antagonist at β1 and β2 adrenergic receptors. Lipophilic; significant blood–brain barrier penetration, accounting for its CNS effects.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| mechanism         = Non-selective competitive antagonist at β1 and β2 adrenergic receptors. Lipophilic; significant blood–brain barrier penetration, accounting for its CNS effects.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| intro             = Propranolol was the first clinically successful beta blocker, introduced in 1964 by James Black. It is non-selective and lipophilic &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;— &lt;/del&gt;it crosses the blood–brain barrier readily, which makes it uniquely useful for conditions with a CNS component (performance anxiety, akathisia, essential tremor, migraine prophylaxis) but also accounts for CNS side effects (vivid dreams, fatigue, depression).&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| intro             = Propranolol was the first clinically successful beta blocker, introduced in 1964 by James Black. It is non-selective and lipophilic&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/ins&gt;it crosses the blood–brain barrier readily, which makes it uniquely useful for conditions with a CNS component (performance anxiety, akathisia, essential tremor, migraine prophylaxis) but also accounts for CNS side effects (vivid dreams, fatigue, depression).&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| indications       =&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| indications       =&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| dosing            =&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| dosing            =&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l27&quot;&gt;Line 27:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 27:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| pregnancy_details =&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| pregnancy_details =&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| monitoring        = Heart rate, blood pressure&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| monitoring        = Heart rate, blood pressure&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| counseling        = Do not stop abruptly &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;— &lt;/del&gt;taper to avoid rebound tachycardia, hypertension, or angina. Use with caution in asthma/COPD. May mask hypoglycemia symptoms in diabetics.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| counseling        = Do not stop abruptly&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;, &lt;/ins&gt;taper to avoid rebound tachycardia, hypertension, or angina. Use with caution in asthma/COPD. May mask hypoglycemia symptoms in diabetics.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| anecdotes         =&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| anecdotes         =&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| seealso           = [[Metoprolol]], [[Bisoprolol]], [[Nebivolol]]&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;| seealso           = [[Metoprolol]], [[Bisoprolol]], [[Nebivolol]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>MDElliottMD</name></author>
	</entry>
	<entry>
		<id>https://pharmacopedia.wiki/index.php?title=Propranolol&amp;diff=3377&amp;oldid=prev</id>
		<title>MDElliottMD: Create Propranolol scaffold</title>
		<link rel="alternate" type="text/html" href="https://pharmacopedia.wiki/index.php?title=Propranolol&amp;diff=3377&amp;oldid=prev"/>
		<updated>2026-05-15T07:15:40Z</updated>

		<summary type="html">&lt;p&gt;Create Propranolol scaffold&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{MedTemplate&lt;br /&gt;
| generic           = Propranolol&lt;br /&gt;
| brand             = Inderal&lt;br /&gt;
| classes           = Beta Blocker, Non-selective&lt;br /&gt;
| uses              = &amp;lt;vote slug=&amp;quot;hypertension-use&amp;quot;&amp;gt;Hypertension&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;migraine-prophylaxis-use&amp;quot;&amp;gt;Migraine prophylaxis&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;performance-anxiety-use&amp;quot;&amp;gt;Performance anxiety&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;essential-tremor-use&amp;quot;&amp;gt;Essential tremor&amp;lt;/vote&amp;gt;, &amp;lt;vote slug=&amp;quot;akathisia-use&amp;quot;&amp;gt;Akathisia&amp;lt;/vote&amp;gt;&lt;br /&gt;
| starting_dose     = 10–40 mg (situational anxiety); 40 mg BID (HTN)&lt;br /&gt;
| preparations      = 10, 20, 40, 60, 80 mg tabs; 60/80/120/160 mg ER caps; 1 mg/mL IV&lt;br /&gt;
| fda_max           = 640 mg/d (HTN); 240 mg/d (migraine)&lt;br /&gt;
| routes            = Oral, IV&lt;br /&gt;
| onset             = 1–2 h (PO), immediate (IV)&lt;br /&gt;
| duration          = 6–12 h (IR); 24 h (ER)&lt;br /&gt;
| halflife          = 3–6 h&lt;br /&gt;
| bioavailability   = ~25% (extensive hepatic first-pass)&lt;br /&gt;
| pregnancy         = Category C&lt;br /&gt;
| legal             = Rx-only in US&lt;br /&gt;
| mechanism         = Non-selective competitive antagonist at β1 and β2 adrenergic receptors. Lipophilic; significant blood–brain barrier penetration, accounting for its CNS effects.&lt;br /&gt;
| intro             = Propranolol was the first clinically successful beta blocker, introduced in 1964 by James Black. It is non-selective and lipophilic — it crosses the blood–brain barrier readily, which makes it uniquely useful for conditions with a CNS component (performance anxiety, akathisia, essential tremor, migraine prophylaxis) but also accounts for CNS side effects (vivid dreams, fatigue, depression).&lt;br /&gt;
| indications       =&lt;br /&gt;
| dosing            =&lt;br /&gt;
| effects           =&lt;br /&gt;
| pk_absorption     = ~25% oral bioavailability due to high hepatic first-pass extraction.&lt;br /&gt;
| pk_distribution   = Highly lipophilic; ~90% plasma protein binding; readily crosses the BBB.&lt;br /&gt;
| pk_metabolism     = Hepatic via CYP2D6, CYP1A2, CYP2C19. Active metabolite: 4-hydroxypropranolol.&lt;br /&gt;
| pk_elimination    = Renal excretion of metabolites; &amp;lt;1% unchanged in urine.&lt;br /&gt;
| pharmacodynamics  =&lt;br /&gt;
| interactions      = &amp;lt;pharmaInteractions/&amp;gt;&lt;br /&gt;
| pregnancy_details =&lt;br /&gt;
| monitoring        = Heart rate, blood pressure&lt;br /&gt;
| counseling        = Do not stop abruptly — taper to avoid rebound tachycardia, hypertension, or angina. Use with caution in asthma/COPD. May mask hypoglycemia symptoms in diabetics.&lt;br /&gt;
| anecdotes         =&lt;br /&gt;
| seealso           = [[Metoprolol]], [[Bisoprolol]], [[Nebivolol]]&lt;br /&gt;
| references        = &amp;lt;references/&amp;gt;&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Beta Blockers]]&lt;br /&gt;
[[Category:Medicines]]&lt;/div&gt;</summary>
		<author><name>MDElliottMD</name></author>
	</entry>
</feed>